Pipeline Moves: Phase transition rate improves for RMS candidate after Phase II/III success
The Clinical Trials Arena team also review assets in oncology, wet AMD and substance abuse.
22 December 2023
22 December 2023
The Clinical Trials Arena team also review assets in oncology, wet AMD and substance abuse.
According to the findings, the trial of JZP150 failed to meet the primary and key secondary endpoints.
The global trial will recruit patients in the US, UK, EU, and Asia among other regions around the world.
The application comes off the back of a single-arm clinical trial that showed sensor’s ability to watch for infiltrations in amounts as low as 0.2 mL of IV fluid.
Lyndra will use the funds to complete a Phase III trial in schizophrenia and schizoaffective disorder for its risperidone candidate.
The FDA previously granted orphan drug designation for RenovoGem to treat pancreatic cancer and bile duct cancer.
Analysing the safety and tolerability of motixafortide monotherapy and along with natalizumab will be the primary objective.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.